PDI Reports 2012 Fourth Quarter and Year End Financial Results Management Will Host Conference Call Tomorrow March 7, 2013 at 8:30am ET PR Newswire PARSIPPANY, N.J., March 6, 2013 PARSIPPANY, N.J., March 6, 2013 /PRNewswire/ --PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the fourth quarter and year ended December 31, 2012. Summary financial and operating highlights include: oFull year 2012 revenue was $126.9 million compared to $157.3 million for 2011. The company's revenue was lower in 2012 compared to 2011 primarily due to the expiration of certain contracts and the timing of initiation of new contract wins. oThe company finished the full year with over $250 million of new multi-year contract wins and renewals, significantly higher than 2011. oOperating loss for 2012 which includes asset impairment charges of $23.5 million was $25.2 million compared to $4.7 million in 2011, however, Adjusted Operating Loss (a non-GAAP measure) for 2012 was $1.0 million compared to $1.8 million in 2011 and a profit of $0.3 million in the fourth quarter of 2012. oAdjusted EBITDA (a non-GAAP measure) for 2012 increased to $2.8 million compared to a loss of $0.1 million for 2011. Condensed Summary Statement of Continuing Operations ($ in thousands, except per share data) (Unaudited) 4th Quarter Ended Year Ended December 31, December 31, 2012 2011 2012 2011 Revenue, net $ 35,632 $ 38,283 $ 126,899 $ 157,291 Gross profit 6,985 8,701 26,860 32,471 Operating expenses: Compensation expense 3,688 4,544 16,414 19,694 Other SG&A 3,013 3,705 11,455 14,590 Asset impairment 23,517 - 23,517 - GroupDCA contingent consideration buyout and - 2,889 - 2,889 related charges Facilities realignment 706 - 706 - Total operating 30,924 11,138 52,092 37,173 expenses Operating loss $(23,939) $ (2,437) $ (25,232) $ (4,702) Other (expense) income, net (13) 119 (28) (14) Provision (benefit) for income (11) (422) 208 (939) tax Loss from continuing $(23,941) $ (1,896) $ (25,468) $ operations (3,777) Diluted loss per share from $ (1.64) $ (0.13) $ $ continuing operations (1.75) (0.26) CEO Comments Commenting on the results, Nancy Lurker, chief executive officer of PDI, Inc. noted, "As anticipated and discussed during the third quarter conference call, revenue for the full year of 2012 was below that of 2011, due primarily to the timing and implementation of new contracts. During 2012 we won more than $250 million in new multi-year contracts and renewals; however, as a result of the timing of these wins and the execution timelines of these contracts, only $40 million impacted revenue in 2012. Looking forward to 2013, we expect revenues to be significantly higher as we continue to gain new business and realize revenue from the 2012 wins. "The gross margin percentage for the full year of 2012 was essentially flat compared to 2011, but, as we previously discussed, due to intensified competitive pressures, is expected to decline in 2013 as new wins with lower margins are executed. From an operating standpoint, we maintained tight cost controls. For the full year of 2012, excluding asset impairment and facilities realignment charges we reduced ongoing compensation expense and other SG&A by approximately $6.4 million compared to 2011 and the Adjusted Operating Loss, which also excludes these charges, was $1.0 million. We also had positive Adjusted EBITDA of $2.8 million for the full year of 2012. Both of these measures were improvements compared to 2011." Ms. Lurker continued, "We entered 2013 with a strong backlog of business under contract and expect our core business to generate significantly higher revenues during the year. Because these higher revenues will generate lower overall margins we will continue to maintain tight controls over ongoing operating expenses. In addition to being a year of revenue growth for PDI, 2013 will also be a year of investment. Given the dynamics of our current core businesses we are committed to continuing to differentiate them and to developing more predictable, higher growth and higher margin business. "To these ends, in 2013 we will: invest in a number of areas that will help differentiate and further strengthen and support our core offerings; aggressively pursue the in-licensing, acquisition or partnering of products that take advantage of and leverage PDI's core commercialization strengths to add more stable and higher margin business; and complete and fund a new Group DCA product offering that will connect health care providers, sales representatives and other promotional channels in a new and unique way. We expect to provide additional detail on these initiatives as the year progresses." Fourth Quarter Business Reviews - Continuing Operations Revenue- For the fourth quarter of 2012, revenue of $35.6 million was $2.7 million lower than the fourth quarter of 2011. Overall, revenue in the Sales Services segment increased slightly but was more than offset by decreases from both the Marketing Services and Product Commercialization segments. oSales Services segment revenue for the fourth quarter of 2012 of $30.7 million was $0.9 million higher than the fourth quarter of 2011. Revenue from new contract wins more than offset the anticipated expiration of certain other contracts. oMarketing Services segment revenue for the fourth quarter of 2012 of $2.1 million was $0.9 million lower than the fourth quarter of 2011. This decrease was primarily due to fewer contract signings by Group DCA. oProduct Commercialization Services segment revenue for the fourth quarter of 2012 was $2.9 million, $2.7 million lower than the fourth quarter of 2011 due to internalization of selected commercialization activities by our customer as of October 1, 2012. Gross Profit- For the fourth quarter of 2012, gross profit of $7.0 million was $1.7 million lower than the fourth quarter of 2011. At the same time, the gross profit percentage decreased to 20% in 2012 from 23% in 2011. oSales Services segment gross profit for the fourth quarter of 2012 of $5.9 million was $0.5 million lower than the fourth quarter of 2011. While revenue was $0.9 million higher in 2012, lower margins were realized on new business. oMarketing Services segment gross profit for the fourth quarter of 2012 of $0.2 million was $0.6 million lower than 2011 as a result of lower revenue and a lower gross profit percentage within the segment. oProduct Commercialization Services segment gross profit for the fourth quarter of 2012 of $0.9 million was $0.6 million lower compared to 2011 as a result of lower revenue due to the internalization of commercialization activities by our customer. Total Operating Expenses- For the fourth quarter of 2012, total operating expenses were $30.9 million compared to $11.1 million in 2011. Included in fourth quarter 2012 expenses are $23.5 million of asset impairment and $0.7 million of facilities realignment charges and included in 2011 expenses is $2.9 million of Group DCA contingent consideration buyout and related charges. Excluding these items, total operating expenses for the fourth quarter of 2012 were $6.7 million; $1.5 million lower than of 2011. The decrease is a result of the company's continuing focus on cost reduction and right-sizing of the business. During the fourth quarter of 2012 the company recorded total asset impairments of $23.5 million. The majority of these asset impairment charges, $22.8 million, were associated with the write-down of goodwill and other intangible assets in the Group DCA business unit within our Marketing Services segment. The company continues to believe in the long-term growth of this business and intends to continue to invest to achieve that growth. However, the recent decline in revenue, the decrease in new business generated and changes in pharmaceutical industry spending, at least in the near term, were factors contributing to the impairment charge. In addition, the company recorded a $0.7 million charge in the fourth quarter of 2012 from the write-down of assets related to the fourth quarter 2011 sale of certain assets of the company's discontinued Pharmakon business unit. During the fourth quarter of 2012 the Marketing Services segment incurred a charge of approximately $0.7 million related to the downsizing of office space related to Group DCA in Parsippany, New Jersey.We are currently seeking to sublet this unused office space. Operating Loss- For the fourth quarter of 2012 the operating loss was $23.9 million, compared to an operating loss of $2.4 million in the fourth quarter of 2011. Excluding the effect of the asset impairment and facilities realignment charges in 2012 and the contingent consideration buyout in 2011, Adjusted Operating Income in the fourth quarter of 2012 was $0.3 million compared to $0.5 million in 2011. Liquidity and Cash Flow- Adjusted EBITDA for the fourth quarter of 2012 was $1.1 million compared to $(1.6) million in the fourth quarter of 2011. Cash and cash equivalents as of December 31, 2012 were $52.8 million, down $11.6 million from December 31, 2011. oThe decrease in cash from December 31, 2011 is primarily attributable to the payments of severance and close-out costs associated with the fourth quarter 2011 sale of our Pharmakon business unit, right-sizing of the Group DCA unit, scheduled payments to the sellers of Group DCA in 2012 and the timing of collection of certain trade receivables. As of December 31, 2012, the company's cash equivalents were predominantly invested in U.S. Treasury money market funds and the company had no commercial debt. Non-GAAP Financial Measures In addition to United States generally accepted accounting principles, or GAAP, results provided throughout this document, PDI has provided certain non-GAAP financial measures to help evaluate the results of its performance. The company believes that these non-GAAP financial measures, when presented in conjunction with comparable GAAP financial measures, are useful to both management and investors in analyzing the company's ongoing business and operating performance. The company believes that providing non-GAAP information to investors, in addition to the GAAP presentation, allows investors to view the company's financial results in the way that management views financial results. In this document, the company discusses Adjusted Operating Income (Loss), a non-GAAP financial measure. Adjusted Operating Income (Loss) is a metric used by management to measure the profitability of the ongoing business. Adjusted Operating Income (Loss) is defined as operating loss, plus asset impairment, Group DCA contingent consideration buyout, and facilities realignment. The table below includes a reconciliation of this non-GAAP financial measure to the most directly comparable GAAP financial measure. Adjusted Operating Income (Loss) (Unaudited) ($ in thousands) 4th Quarter Ended Year Ended December 31, December 31, 2012 2011 2012 2011 Operating loss $ (23,939) $ (2,437) $ (25,232) $ (4,702) Asset impairment 23,517 - 23,517 - Group DCA contingent consideration buyout and - 2,889 - 2,889 related charges Facilities realignment 706 - 706 - Adjusted operating income $ $ $ (1,009) $ (1,813) (loss) 284 452 In this document, the company also discusses Adjusted EBITDA, a non-GAAP financial measure. Adjusted EBITDA is a metric used by management to measure cash flow of the ongoing business. Adjusted EBITDA is defined as operating loss, plus depreciation and amortization, non-cash stock-based compensation, and other non-cash expenses. The table below includes a reconciliation of this non-GAAP financial measure to the most directly comparable GAAP financial measure. Adjusted EBITDA (Unaudited) ($ in thousands) 4th Quarter Ended Year Ended December 31, December 31, 2012 2011 2012 2011 Operating loss $ (23,939) $ $ $ (2,437) (25,232) (4,702) Depreciation and 544 599 2,034 2,665 amortization Stock compensation 271 253 1,791 1,936 Asset impairment 23,517 - 23,517 - Facilities realignment 706 - 706 - Adjusted EBITDA $ $ $ $ 1,099 (1,585) 2,816 (101) Conference Call As previously announced, PDI will hold a conference call tomorrow, Thursday, March 7 to discuss financial and operational results for the fourth quarter and year ended December 31, 2012 as follows: Time: 8:30 AM (ET) Dial-in numbers: (866) 644-4654 (U.S. and Canada) or (706) 643-1203 Conference ID#: 98411955 Live webcast: www.pdi-inc.com, under "Investor Relations" The teleconference replay will be available three hours after completion through March 11, 2013 at (800) 585-8367 (U.S. and Canada) or (404) 537-3406. The replay pass code is 98411955. The archived web cast will be available for one year. About PDI, Inc. PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise. For more information, please visit the company's website at http://www.pdi-inc.com. Forward-Looking Statements This press release contains forward-looking statements regarding future events and financial performance. These statements are based on current expectations and assumptions involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control. These statements also involve known and unknown risks, uncertainties and other factors that may cause PDI's actual results to be materially different from those expressed or implied by any forward-looking statement. For example, with respect to statements regarding projections of future revenues, growth and profitability, actual results may differ materially from those set forth in this release based on the loss, early termination or significant reduction of any of our existing service contracts, the failure to meet performance goals in PDI's incentive-based arrangements with customers, the inability to secure additional business or our inability to develop more predictable, higher margin business through in-licensing or other means. Additionally, all forward-looking statements are subject to the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's subsequently filed Annual Report on Form 10-K for the year ended December 31, 2012 and current reports on Form 8-K. Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements. In addition, these statements speak only as of the date of this press release and, except as may be required by law, PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason. (Tables to Follow) PDI, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) ($ in thousands, except per share data) Three Months Ended Years Ended December 31, December 31, 2012 2011 2012 2011 Revenue, net $ 35,632 $ 38,283 $ 126,899 $ 157,291 Cost of services 28,647 29,582 100,039 124,820 Gross profit 6,985 8,701 26,860 32,471 Compensation expense 3,688 4,544 16,414 19,694 Other selling, general and administrative 3,013 3,705 11,455 14,590 expenses Asset impairment 23,517 - 23,517 - GroupDCA contingent consideration buyout and - 2,889 - 2,889 related charges Facilities realignment 706 - 706 - Total operating expenses 30,924 11,138 52,092 37,173 Operating loss (23,939) (2,437) (25,232) (4,702) Other (expense) income, (13) 119 (28) (14) net Loss from continuing operations before income tax (23,952) (2,318) (25,260) (4,716) (Benefit) provision for (11) (422) 208 (939) income tax Loss from continuing (23,941) (1,896) (25,468) (3,777) operations Income (loss) from discontinued operations, 145 (8,369) (59) (8,137) net of tax Net loss $ (23,796) $ (10,265) $ (25,527) $ (11,914) Basic and diluted (loss) income per share of common stock: From continuing $ (1.64) $ (0.13) $ $ operations (1.75) (0.26) From discontinued 0.01 (0.58) - (0.57) operations Net loss per basic and $ $ diluted share of common $ (1.63) $ (0.71) (1.75) (0.83) stock Weighted average number of common shares and common share equivalents outstanding: Basic 14,627 14,496 14,585 14,440 Diluted 14,627 14,496 14,585 14,440 Segment Data (Unaudited) ($ in thousands) Sales Marketing PC Services Services Services* Consolidated Three months ended December 31, 2012: Revenue, net $ 30,667 $ 2,066 $ 2,899 $ 35,632 Gross profit $ 5,938 $ 196 $ 851 $ 6,985 Gross profit % 19.4% 9.5% 29.4% 19.6% Three months ended December 31, 2011: Revenue, net $ 29,762 $ 2,929 $ 5,592 $ 38,283 Gross profit $ 6,485 $ 806 $ 1,410 $ 8,701 Gross profit % 21.8% 27.5% 25.2% 22.7% Year ended December 31, 2012: Revenue, net $ 99,206 $ 10,127 $ 17,566 $ 126,899 Gross profit $ 19,076 $ 2,887 $ 4,897 $ 26,860 Gross profit % 19.2% 28.5% 27.9% 21.2% Year ended December 31, 2011: Revenue, net $ 135,970 $ 12,195 $ 9,126 $ 157,291 Gross profit $ 27,200 $ 3,051 $ 2,220 $ 32,471 Gross profit % 20.0% 25.0% 24.3% 20.6% * Product Commercialization (PC) Services Selected Balance Sheet Data (Unaudited) ($ in thousands) December 31, December 31, 2012 2011 Cash and cash equivalents $ 52,783 $ 64,337 Total current assets $ 71,583 $ 80,360 Total current liabilities 36,390 46,078 Working capital $ 35,193 $ 34,282 Total assets $ 78,447 $ 113,379 Total liabilities $ 42,817 $ 53,856 Total stockholders' equity $ 35,630 $ 59,523 Selected Cash Flow Data (Unaudited) ($ in thousands) December 31, 2012 2011 Net loss $ (25,527) $ (11,914) Non-cash items: Depreciation and amortization 2,034 3,046 Stock-based compensation 1,791 1,936 Other 23,744 5,530 Net change in assets and liabilities (12,328) 3,387 Net cash (used in) provided by operations $ (10,286) $ 1,985 Change in cash and cash equivalents $ (11,554) $ 1,626 SOURCE PDI, Inc. Website: http://www.pdi-inc.com Contact: INVESTORS AND MEDIA - Melody Carey, Rx Communications Group, LLC, +1-917-322-2571, Mcarey@RxIR.com
PDI Reports 2012 Fourth Quarter and Year End Financial Results
Press spacebar to pause and continue. Press esc to stop.